Tekla Healthcare Investors Stock Price To Earning
| HQH Stock | USD 16.82 0.52 3.00% |
Tekla Healthcare Investors fundamentals help investors to digest information that contributes to Tekla Healthcare's financial success or failures. It also enables traders to predict the movement of Tekla Stock. The fundamental analysis module provides a way to measure Tekla Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tekla Healthcare stock.
Tekla |
Tekla Healthcare Investors Company Price To Earning Analysis
Tekla Healthcare's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Tekla Healthcare Price To Earning | 3.38 X |
Most of Tekla Healthcare's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tekla Healthcare Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Tekla Healthcare Investors has a Price To Earning of 3.38 times. This is 81.51% lower than that of the Capital Markets sector and 76.79% lower than that of the Financials industry. The price to earning for all United States stocks is 88.23% higher than that of the company.
Tekla Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tekla Healthcare's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tekla Healthcare could also be used in its relative valuation, which is a method of valuing Tekla Healthcare by comparing valuation metrics of similar companies.Tekla Healthcare is currently under evaluation in price to earning category among related companies.
Tekla Fundamentals
| Return On Equity | 0.061 | |||
| Return On Asset | -8.0E-4 | |||
| Profit Margin | 5.47 % | |||
| Operating Margin | (0.22) % | |||
| Current Valuation | 864.74 M | |||
| Shares Outstanding | 50.62 M | |||
| Shares Owned By Institutions | 26.67 % | |||
| Number Of Shares Shorted | 36.82 K | |||
| Price To Earning | 3.38 X | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 76.62 X | |||
| Revenue | 58.12 M | |||
| Gross Profit | 8.27 M | |||
| EBITDA | 56.33 M | |||
| Net Income | 56.33 M | |||
| Cash And Equivalents | 62 | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 3.21 X | |||
| Book Value Per Share | 18.84 X | |||
| Cash Flow From Operations | (65.41 M) | |||
| Short Ratio | 0.18 X | |||
| Earnings Per Share | 1.09 X | |||
| Number Of Employees | 13 | |||
| Beta | 0.74 | |||
| Market Capitalization | 885.43 M | |||
| Total Asset | 932.49 M | |||
| Retained Earnings | 5.97 M | |||
| Annual Yield | 0.09 % | |||
| Five Year Return | 8.90 % | |||
| Net Asset | 932.49 M | |||
| Last Dividend Paid | 1.61 |
About Tekla Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:Check out Tekla Healthcare Piotroski F Score and Tekla Healthcare Altman Z Score analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Tekla Stock analysis
When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stocks Directory Find actively traded stocks across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Tekla Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.